-
GHO Capital acquires Ardena
Jan 14, 2020, 03:18 AM by Michael CroftGHENT, BELGIË - Jan 9, 2020 - London, UK – Global Healthcare Opportunities, or GHO Capital Partners LLP, the European specialist investor in healthcare, together with the existing management team has acquired Ardena, a specialist contract development and manufacturing organization (CDMO) focused on early phase drug development, from Mentha CapitalFull story -
Rho partners with TRI to provide centralized and risk-based quality management technology to their clients
Jan 13, 2020, 13:42 PM by Michael CroftDURHAM, NC - Jan 13, 2020 - For Immediate ReleaseRho partners with TRI to provide centralized and risk-based quality management technology to their clients Research Triangle Park, NC - January 13, 2020 - Rho, a full-service contract research organization (CRO) focused on bringing new products to market through a full range of product development services, announced today that it has partnered with Triumph Research Intelligence (TRI), a global leader in centralized and risk-based quality management (RBQM) technologyFull story -
Diagnostics Partnerships, New Sequencers, Technical Advances From Illumina
Jan 13, 2020, 12:25 PM by Michael CroftBio-IT World | Francis deSouza, CEO of Illumina, gave his report this morning at the annual JP Morgan Healthcare Conference. Just days after terminating the planned merger between Illumina and Pacific Biosciences, deSouza was positive about Illumina’s outlook for 2020, announcing agreements with Roche and Genomics England as well as new sequencers and technical advances. “I have never been more excited about the opportunity for Illumina as we enter 2020,” he said.Full story -
Aquestive Therapeutics Receives FDA Response to Citizen’s Petition
Jan 13, 2020, 09:28 AM by Michael CroftNEW YORK, NY, UNITED STATES - Jan 13, 2020 - Aquestive Therapeutics, Inc. (NASDAQ: AQST), a specialty pharmaceutical company focused on developing and commercializing differentiated products that meet patients unmet needs and solve therapeutic problems, today reported that the UFull story -
Creative Biolabs Provides Anti-Human CXCL12 Therapeutic Antibody for Research Use
Jan 12, 2020, 01:13 AM by Michael CroftSHIRLEY, NY - Jan 12, 2020 - January 12, 2020, Creative Biolabs, as a leading supplier in the recombinant antibody (rAb) discovery and manufacturing, announced the newly-developed product CXCL12 for research useFull story -
Avoid These Eight Costly Biospecimen Procurement Mistakes
Jan 10, 2020, 08:25 AM by Michael CroftFull storyBio-IT World Contributed Commentary | Every day counts when it comes to saving lives and generating revenue, especially when you’re trying to bring a drug, treatment, or diagnostic tool to market. Unfortunately, these processes often take a lot longer and cost a lot more than initially expected.
-
Top 10 Stories of 2019: National Genomic Data Initiatives, AI’s Impact in Drug Development, And More
Jan 9, 2020, 10:00 AM by Michael CroftFull storyBio-IT World | As we head into 2020, we at Bio-IT World would like to take a moment and reflect on the groundbreaking achievements from this past year. In that spirit, here are the top 10 stories of 2019, ranked in order of popularity.
-
Sano Genetics Deploys Lifebit CloudOS, Delivers Free Genotype Imputation for Direct to Consumer (DTC) Genetics Customers
Jan 9, 2020, 07:07 AM by Michael CroftLONDON, UK - Jan 9, 2020 - Lifebit Biotech, a leading innovator in bioinformatics and cognitive software solutions, and Sano Genetics, the biotech company that connects people with research studies, announced today the deployment of Lifebit CloudOS to power the Sano Genetics platform, achieving 35% increase in speed of imputation analyses with data security guaranteedFull story -
How To Improve Biopharmaceutical Research Data Utilization?
Jan 8, 2020, 11:00 AM by Michael CroftFull storyBio-IT World Contributed Commentary | Many enterprise network security people intuitively put everything behind a firewall—even though it has been well-established that firewalls are big hindrance to high-speed data flows. There are a few reasons of poor data mobility and thus low utilization.
-
Kyruus Raises $42 Million in New Financing After Delivering Another Year of Record Growth
Jan 8, 2020, 10:35 AM by Michael CroftBOSTON, MA, UNITED STATES - Jan 8, 2020 - Kyruus, the leader in provider search and scheduling solutions for health systems, today announced that it raised $42 million in new financing in a Series D round that brings its total funding to more than $125 million since its founding in 2010Full story -
MDI Biological Scientists Identify Pathways That Extend Lifespan by 500%
Jan 8, 2020, 09:33 AM by Michael CroftBAR HARBOR, ME, UNITED STATES - Jan 8, 2020 - Scientists at the MDI Biological Laboratory, in collaboration with scientists from the Buck Institute for Research on Aging in Novato, CalifFull story -
Certara Partners with Galderma in Advancing Modeling and Simulation Technology to Attain FDA Approval of AKLIEF® Topical Acne Cream
Jan 8, 2020, 08:29 AM by Michael CroftPRINCETON, NJ - Jan 8, 2020 - Certara®, the global model-informed drug development and decision support leader, today announced that its Simcyp® Population-based Simulator was used to support Full storyFollow the Money: New Life Sciences Investment Firm, Funding for Deep Genomics, Verantos, TwinStrand Biosciences, More
Jan 7, 2020, 14:15 PM by Michael CroftBio-IT World Perceptive Advisors launches a new venture capital fund for early-stage life sciences companies. Deep Genomics closes its series B round to fund its AI-powered drug discovery platform. Several molecular diagnostics companies receive funding to advance PCR platforms and companion diagnostics. TwinStrand Biosciences closes a Series A fund to create a new genomic sequencing technology, and more.Full story30 Health Systems Take United Action to Treat Substance Use Disorder and Addiction
Jan 7, 2020, 13:31 PM by Michael CroftCHICAGO, IL, UNITED STATES - Jan 7, 2020 - CHICAGO - January 7, 2020 - In response to the national opioid epidemic and the prevalence of other Substance Use Disorders (SUD) in the UFull storyAbsolute Antibody Launches VivopureX™ Recombinant Antibodies for In Vivo Research
Jan 7, 2020, 10:16 AM by Michael CroftREDCAR, UNITED KINGDOM - Jan 7, 2020 - Absolute Antibody Ltd., an industry-leading provider of recombinant antibody products and services, today announced the launch of its VivopureX™ recombinant mouse antibodies for in vivo research in mouse modelsFull storySignant Health Partners with Propeller Health to Gather Accurate Data on Asthma and COPD Medication Use
Jan 7, 2020, 10:03 AM by Michael CroftPHILADELPHIA, PA - Jan 7, 2020 - Signant Health announced today a partnership to connect TrialMax®, the industry-leading electronic Clinical Outcome Assessment (eCOA) platform, to Propeller Healths digital health platform for asthma and COPD (chronic obstructive pulmonary disease)Full storyHeart-In-A-Jar Platform Humanizing Preclinical Research
Jan 6, 2020, 14:00 PM by Michael CroftFull storyBio-IT World | Stem cell biotech company Novoheart has been bioengineering miniature human hearts as a platform for drug discovery and development for several to pharmaceutical firms, notably for human conditions without a good animal model for preclinical testing. Novoheart’s thumb-sized human “heart-in-a-jar” models can both contract and eject blood-like fluid, making it possible to measure how well the heart is pumping.
Quantum Dot Display Market Resurgent on Back of Strong Growth of Consumer Electronics Industry, Finds Fact.MR
Jan 6, 2020, 10:16 AM by Michael CroftDUBLIN, IRELAND - Jan 6, 2020 - Exponential growth in demand for high definition display panels for electronic devices is powering the quantum dot display market ahead, with growth pegged at an astounding CAGR of over 30% during the forecast period (2019 - 2027)Full storyVERICHEM LABORATORIES OFFERS NIST TRACEABLE, LIQUID STABLE, STANDARD KIT FOR URINE URIC ACID TESTING
Jan 5, 2020, 11:49 AM by Michael CroftPROVIDENCE, NY - Jan 5, 2020 - A ready-to-use, liquid stable standard kit for Urine Uric Acid testing is now available from VERICHEM LABORATORIESFull storyKeeping It Real: Challenges And Benefits Of Integrating AI And Machine Learning Into Pharma R&D
Jan 3, 2020, 06:40 AM by Michael CroftFull storyBio-IT World Contributed Commentary | Productivity in the pharmaceutical industry is rapidly declining. This crisis has created a need to re-think the way clinical trials are conceived, designed and conducted. As such, artificial intelligence is poised to transform the industry.